These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8237996)

  • 1. Synergistic effect of storage pool deficient platelets and low plasma von Willebrand factor on the severity of the hemorrhagic diathesis in Hermansky-Pudlak syndrome.
    Witkop CJ; Bowie EJ; Krumwiede MD; Swanson JL; Plumhoff EA; White JG
    Am J Hematol; 1993 Dec; 44(4):256-9. PubMed ID: 8237996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet von Willebrand factor in Hermansky-Pudlak syndrome.
    McKeown LP; Hansmann KE; Wilson O; Gahl W; Gralnick HR; Rosenfeld KE; Rosenfeld SJ; Horne MK; Rick ME
    Am J Hematol; 1998 Oct; 59(2):115-20. PubMed ID: 9766795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Albinism and Hermansky-Pudlak syndrome in Puerto Rico.
    Witkop CJ; Nuñez Babcock M; Rao GH; Gaudier F; Summers CG; Shanahan F; Harmon KR; Townsend D; Sedano HO; King RA
    Bol Asoc Med P R; 1990 Aug; 82(8):333-9. PubMed ID: 2261023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of the ABO blood type on the distribution of von Willebrand factor in healthy children with no bleeding symptoms.
    Akin M; Balkan C; Karapinar DY; Kavakli K
    Clin Appl Thromb Hemost; 2012 Jun; 18(3):316-9. PubMed ID: 21949039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of ABO blood group on von Willebrand factor tests in healthy Saudi blood donors.
    Alharbi A; Hassan SB; Al-Momen AK; Al-Saleh K; Nasr R; Kohgear H; Owaidah T
    Blood Coagul Fibrinolysis; 2018 Mar; 29(2):211-215. PubMed ID: 29369083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of recessive severe type 1 and 3 von Willebrand Disease (VWD), asymptomatic heterozygous carriers versus bloodgroup O-related von Willebrand factor deficiency, and dominant type 1 VWD.
    Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van de Velde A; van Vliet H
    Clin Appl Thromb Hemost; 2006 Jul; 12(3):277-95. PubMed ID: 16959681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hermansky-Pudlak syndrome (HPS). An epidemiologic study.
    Witkop CJ; Almadovar C; Piñeiro B; Nuñez Babcock M
    Ophthalmic Paediatr Genet; 1990 Sep; 11(3):245-50. PubMed ID: 2280982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of ABO(H) and I blood group system development with von Willebrand factor and Factor VIII plasma levels in children and adolescents.
    Klarmann D; Eggert C; Geisen C; Becker S; Seifried E; Klingebiel T; Kreuz W
    Transfusion; 2010 Jul; 50(7):1571-80. PubMed ID: 20210927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of exercise, DDAVP, and epinephrine on the factor VIII:C/von Willebrand factor complex in normal dogs and von Willebrand factor deficient Doberman pinscher dogs.
    Meyers KM; Wardrop KJ; Dodds WJ; Brassard J
    Thromb Res; 1990 Jan; 57(1):97-108. PubMed ID: 2105540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linkage disequilibrium mapping of the gene for Hermansky-Pudlak syndrome to chromosome 10q23.1-q23.3.
    Fukai K; Oh J; Frenk E; Almodóvar C; Spritz RA
    Hum Mol Genet; 1995 Sep; 4(9):1665-9. PubMed ID: 8541858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of bleeding phenotype in adult patients with moderate or severe von Willebrand disease.
    de Wee EM; Sanders YV; Mauser-Bunschoten EP; van der Bom JG; Degenaar-Dujardin ME; Eikenboom J; de Goede-Bolder A; Laros-van Gorkom BA; Meijer K; Hamulyák K; Nijziel MR; Fijnvandraat K; Leebeek FW;
    Thromb Haemost; 2012 Oct; 108(4):683-92. PubMed ID: 22918553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of von Willebrand factor levels in young women with and without bleeding symptoms: influence of ABO blood group and promoter haplotypes.
    Lethagen S; Hillarp A; Ekholm C; Mattson E; Halldén C; Friberg B
    Thromb Haemost; 2008 Jun; 99(6):1013-8. PubMed ID: 18521502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baseline factor VIII plasma levels and age at first bleeding in patients with severe forms of von Willebrand disease.
    Siboni SM; Biguzzi E; Caiani V; Mistretta C; Bucciarelli P; Peyvandi F
    Haemophilia; 2016 Jul; 22(4):564-9. PubMed ID: 26843468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
    Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
    Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Von Willebrand's disease: case report and review of literature.
    Echahdi H; El Hasbaoui B; El Khorassani M; Agadr A; Khattab M
    Pan Afr Med J; 2017; 27():147. PubMed ID: 28904675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of von Willebrand factor in platelets of patients with various forms of von Willebrand disease: is there a clinical relevance?
    Kertzscher F; Müller AE; Lenk H
    Eur J Pediatr; 1999 Dec; 158 Suppl 3():S177-9. PubMed ID: 10650864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Impact of vWF gene A1381T polymorphism and ABO blood group on von Willebrand factor level in plasma].
    Yuan ZH; Zhao J; Zhang Y; Zhu P
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Aug; 18(4):967-71. PubMed ID: 20723310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implications.
    Michiels JJ; van de Velde A; van Vliet HH; van der Planken M; Schroyens W; Berneman Z
    Semin Thromb Hemost; 2002 Apr; 28(2):111-32. PubMed ID: 11992235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between von Willebrand factor antigen, von Willebrand factor ristocetin cofactor activity and factor VIII activity in plasma.
    Lippi G; Franchini M; Salvagno GL; Montagnana M; Poli G; Guidi GC
    J Thromb Thrombolysis; 2008 Oct; 26(2):150-3. PubMed ID: 17786534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of a bleeding tendency in severe acquired von Willebrand's disease. The role of platelet von Willebrand factor in maintaining normal hemostasis.
    Drouin J; Lillicrap DP; Izaguirre CA; Sutherland M; Windsor S; Benford K; Hoogendorn H; Giles AR
    Am J Clin Pathol; 1989 Oct; 92(4):471-8. PubMed ID: 2508465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.